BIOMARIN PHARMACEUTICAL INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,740 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 251-275 of 1,000 matching filings.

Per page
25
Current page
11
SC 13G File 005-56595

SEC SCHEDULE 13G

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SC 13G/A filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
09 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Dec 2023
Reporting date
21 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
21 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
13 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2023
Reporting date
04 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Dec 2023
Reporting date
01 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
05 Dec 2023
Reporting date
01 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Dec 2023
Reporting date
01 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Dec 2023
Reporting date
01 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .